Odonate Therapeutics, Inc. Common Stock
ODT was delisted on the 14th of January, 2022.
55 hedge funds and large institutions have $361M invested in Odonate Therapeutics, Inc. Common Stock in 2018 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 17 increasing their positions, 22 reducing their positions, and 6 closing their positions.
50% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 6
6% more funds holding
Funds holding: 52 → 55 (+3)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
23% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 22
25% less capital invested
Capital invested by funds: $480M → $361M (-$119M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCM
Tang Capital Management
San Diego,
California
|
+$3.9M |
| 2 |
BC
Boxer Capital
San Diego,
California
|
+$2.36M |
| 3 |
Janus Henderson Group
London,
United Kingdom
|
+$2.22M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$1.85M |
| 5 |
Morgan Stanley
New York
|
+$1.21M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SAAM
Solus Alternative Asset Management
Summit,
New Jersey
|
-$5.78M |
| 2 |
RG
Redmile Group
San Francisco,
California
|
-$2.31M |
| 3 |
PA
Perceptive Advisors
New York
|
-$1.94M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.54M |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
-$1.43M |
ODT Hedge Fund Activity: Q4 2018 in Review
55 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Odonate Therapeutics, Inc. Common Stock (ODT) for Q4 2018, worth a combined $361M — down 25% from $480M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new ODT positions and 6 closed out — a net gain of 3 holders — while 17 added to existing stakes and 22 trimmed.
The largest buyer was Tang Capital Management, adding an estimated $3.9M. The largest seller was Solus Alternative Asset Management, cutting an estimated $5.78M.
- 55 institutional investors held Odonate Therapeutics, Inc. Common Stock (ODT) as of Q4 2018, up from 52 in Q3 2018.
- Funds reported $361M of Odonate Therapeutics, Inc. Common Stock stock for Q4 2018, down 25% quarter-over-quarter.
- 9 funds opened new Odonate Therapeutics, Inc. Common Stock positions in Q4 2018 and 6 closed out, a net change of +3 holders.
- The largest Odonate Therapeutics, Inc. Common Stock buyer in Q4 2018 was Tang Capital Management, an estimated $3.9M added.
- The largest Odonate Therapeutics, Inc. Common Stock seller in Q4 2018 was Solus Alternative Asset Management, an estimated $5.78M sold.
Based on aggregated 13F filings for Q4 2018.